Evidence map›Paper›PMID 30889631›Full record

ArticleAntiviral chemistry & chemotherapy2015

Synthesis of multi ring-fused imidazo [1,2- a]isoquinoline-based fluorescent scaffold as anti-Herpetic agent.

Harapriya Chakravarty, Durbadal Ojha, Ananda K Konreddy, Chandralata Bal, Nidhi S Chandra, Ashoke Sharon, Debprasad Chattopadhyay

Open access · bronzeAbstract read
In one paragraph

Article in Antiviral chemistry & chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Harapriya Chakravarty1 Department of Chemistry, Birla Institute of Technology, Mesra, India.
Durbadal Ojha2 ICMR Virus Unit, ID & BG Hospital, Kolkata, India.
Ananda K Konreddy1 Department of Chemistry, Birla Institute of Technology, Mesra, India.
Chandralata Bal1 Department of Chemistry, Birla Institute of Technology, Mesra, India.
Nidhi S Chandra2 ICMR Virus Unit, ID & BG Hospital, Kolkata, India.
Ashoke Sharon1 Department of Chemistry, Birla Institute of Technology, Mesra, India.
Debprasad Chattopadhyay2 ICMR Virus Unit, ID & BG Hospital, Kolkata, India.
Birla Institute of Technology, Mesra · INVirus Unit · INRegional Medical Research Center · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNatural product-inspired synthesis is a key incorporation in modern diversity-oriented synthesis to yield biologically novel scaffold. Inspired by β-carboline fused system, we have designed molecules with multi ring fused scaffold by modifying the tricyclic pyrido[3,4- b]indole ring with imidazo[1,2- a]isoquinoline.

methodsA highly convergent approach with new C-N and C-C bond formation to synthesize multiring fused complex scaffold imidazo[1,2- a]isoquinolinies as fluorophores. N-nucleophile-induced ring transformation of 2 H-pyran-2-one followed by in situ cis-stilbene-type oxidative photocyclization yielded new C-C bond formation without additional oxidant. The cytotoxicity, effective concentrations, and the mode of action of the synthesized analogs were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),, plaque reduction, time of addition, and reverse transcriptase Polymerase Chain Reaction (PCR).

resultsNovel imidazo[1,2- a]isoquinoline analogs were prepared, and the results revealed that trans isomer of cyclopropyl analog (EC

conclusionNovel imidazo[1,2- a]isoquinoline analogs were synthesized from pyranone with appropriate amines. Two compounds showed better antiviral profile on HSV-infected Vero cells, compared to the standard drug acyclovir (ACV). Overall, we discovered a promising scaffold to develop a nonnucleoside lead targeting the viral immediate early transcription for the management of HSV infections.

Indexed as

Antiviral AgentsDNA, ViralDose-Response Relationship, DrugFluorescent DyesImidazolesIsoquinolinesMicrobial Sensitivity TestsMolecular StructureSimplexvirusStructure-Activity RelationshipAntiviral AgentsDNA, ViralFluorescent DyesImidazolesIsoquinolines2-]isoquinolineherpes simplex virusImidazo[1immediate early transcription

Identifiers

PMID30889631
PMCPMC5890510
OpenAlexW2568827365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.